Wedge Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-37,663
Closed -$3.41M 558
2026
Q1
$3.41M Sell
37,663
-12,439
-25% -$1.14M 0.06% 248
2025
Q4
$4.51M Sell
50,102
-13,812
-22% -$1.31M 0.08% 224
2025
Q3
$6.3M Sell
63,914
-17,263
-21% -$1.71M 0.11% 196
2025
Q2
$7.4M Sell
81,177
-12,302
-13% -$1.19M 0.13% 166
2025
Q1
$10.6M Sell
93,479
-12,441
-12% -$1.33M 0.2% 126
2024
Q4
$11.2M Buy
105,920
+1,688
+2% +$181K 0.2% 127
2024
Q3
$11.3M Buy
104,232
+13,497
+15% +$1.47M 0.19% 145
2024
Q2
$9.85M Sell
90,735
-6,630
-7% -$782K 0.17% 144
2024
Q1
$12.9M Sell
97,365
-26,457
-21% -$3.3M 0.21% 137
2023
Q4
$15.1M Buy
123,822
+4,000
+3% +$446K 0.27% 100
2023
Q3
$13.4M Sell
119,822
-3,176
-3% -$403K 0.27% 111
2023
Q2
$17.9M Sell
122,998
-89,994
-42% -$12.2M 0.29% 110
2023
Q1
$27.5M Sell
212,992
-47,878
-18% -$6.01M 0.46% 83
2022
Q4
$33.3M Sell
260,870
-71,299
-21% -$8.27M 0.54% 66
2022
Q3
$34.7M Sell
332,169
-17,376
-5% -$1.91M 0.59% 59
2022
Q2
$36.7M Sell
349,545
-39,280
-10% -$4.66M 0.58% 54
2022
Q1
$49.7M Sell
388,825
-20,164
-5% -$2.43M 0.67% 33
2021
Q4
$50.4M Buy
408,989
+72,731
+22% +$9.52M 0.62% 39
2021
Q3
$47.8M Sell
336,258
-28,237
-8% -$4.15M 0.62% 39
2021
Q2
$56.9M Sell
364,495
-21,070
-5% -$3.41M 0.7% 39
2021
Q1
$59.9M Sell
385,565
-399,955
-51% -$62M 0.71% 37
2020
Q4
$118M Sell
785,520
-77,715
-9% -$11M 1.36% 2
2020
Q3
$114M Buy
863,235
+163,535
+23% +$21.4M 1.53% 3
2020
Q2
$81.1M Sell
699,700
-96,694
-12% -$11.1M 1.11% 11
2020
Q1
$78.2M Sell
796,394
-112,123
-12% -$14.7M 1.35% 4
2019
Q4
$132M Sell
908,517
-92,375
-9% -$12.8M 1.47% 5
2019
Q3
$133M Sell
1,000,892
-164,043
-14% -$21.2M 1.55% 4
2019
Q2
$133M Sell
1,164,935
-53,924
-4% -$6.32M 1.52% 4
2019
Q1
$151M Sell
1,218,859
-14,983
-1% -$1.7M 1.72% 4
2018
Q4
$124M Sell
1,233,842
-122,261
-9% -$13.7M 1.53% 5
2018
Q3
$173M Sell
1,356,103
-124,884
-8% -$14.8M 1.66% 7
2018
Q2
$160M Sell
1,480,987
-76,819
-5% -$8.36M 1.57% 6
2018
Q1
$165M Buy
1,557,806
+55,641
+4% +$6.46M 1.58% 6
2017
Q4
$176M Buy
1,502,165
+8,359
+0.6% +$945K 1.58% 7
2017
Q3
$170M Buy
1,493,806
+70,264
+5% +$8.11M 1.58% 5
2017
Q2
$177M Sell
1,423,542
-43,259
-3% -$5.13M 1.7% 4
2017
Q1
$174M Sell
1,466,801
-61,201
-4% -$6.94M 1.67% 4
2016
Q4
$153M Buy
1,528,002
+313,448
+26% +$33.6M 1.48% 2
2016
Q3
$153M Sell
1,214,554
-45,433
-4% -$5.61M 1.54% 2
2016
Q2
$147M Sell
1,259,987
-29,360
-2% -$3.32M 1.53% 3
2016
Q1
$133M Buy
1,289,347
+146,758
+13% +$14.2M 1.39% 9
2015
Q4
$114M Sell
1,142,589
-23,438
-2% -$2.29M 1.2% 15
2015
Q3
$106M Buy
+1,166,027
New +$117M 1.12% 17
2014
Q2
Sell
-513,167
Closed -$47.1M 595
2014
Q1
$47.1M Sell
513,167
-834
-0.2% -$76.9K 0.49% 67
2013
Q4
$46.5M Buy
514,001
+37,930
+8% +$3.28M 0.49% 66
2013
Q3
$38M Sell
476,071
-1,447
-0.3% -$114K 0.44% 85
2013
Q2
$34.7M Buy
+477,518
New +$35.7M 0.42% 90

Other funds holding ZBH

Wedge Capital Management's ZBH Position: Q2 2026 in Review

Wedge Capital Management sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 37,663 shares — an estimated $3.41M sold.

Wedge Capital Management first reported a position in ZBH in Q2 2013 and held it in 47 quarters. The position peaked at $177M in Q2 2017. 113 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Wedge Capital Management reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
  • Wedge Capital Management sold 37,663 Zimmer Biomet shares in Q2 2026, an estimated $3.41M.
  • Wedge Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 47 quarters.
  • Wedge Capital Management's Zimmer Biomet position peaked at $177M in Q2 2017.
  • 113 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.